191 related articles for article (PubMed ID: 23645172)
21. Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology.
Cochrane A; Albers HJ; Passier R; Mummery CL; van den Berg A; Orlova VV; van der Meer AD
Adv Drug Deliv Rev; 2019 Feb; 140():68-77. PubMed ID: 29944904
[TBL] [Abstract][Full Text] [Related]
22. Microfluidic cell chips for high-throughput drug screening.
Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
[TBL] [Abstract][Full Text] [Related]
23. Microprinting of liver micro-organ for drug metabolism study.
Chang RC; Emami K; Jeevarajan A; Wu H; Sun W
Methods Mol Biol; 2011; 671():219-38. PubMed ID: 20967633
[TBL] [Abstract][Full Text] [Related]
24. Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases.
Paloschi V; Sabater-Lleal M; Middelkamp H; Vivas A; Johansson S; van der Meer A; Tenje M; Maegdefessel L
Cardiovasc Res; 2021 Dec; 117(14):2742-2754. PubMed ID: 33729461
[TBL] [Abstract][Full Text] [Related]
25. Organ-on-a-chip technology and microfluidic whole-body models for pharmacokinetic drug toxicity screening.
Lee JB; Sung JH
Biotechnol J; 2013 Nov; 8(11):1258-66. PubMed ID: 24038956
[TBL] [Abstract][Full Text] [Related]
26. Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering.
Perestrelo AR; Águas AC; Rainer A; Forte G
Sensors (Basel); 2015 Dec; 15(12):31142-70. PubMed ID: 26690442
[TBL] [Abstract][Full Text] [Related]
27. Microfluidic cell culture models for tissue engineering.
Inamdar NK; Borenstein JT
Curr Opin Biotechnol; 2011 Oct; 22(5):681-9. PubMed ID: 21723720
[TBL] [Abstract][Full Text] [Related]
28. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
29. Organs-on-Chips with combined multi-electrode array and transepithelial electrical resistance measurement capabilities.
Maoz BM; Herland A; Henry OYF; Leineweber WD; Yadid M; Doyle J; Mannix R; Kujala VJ; FitzGerald EA; Parker KK; Ingber DE
Lab Chip; 2017 Jun; 17(13):2294-2302. PubMed ID: 28608907
[TBL] [Abstract][Full Text] [Related]
30. Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture.
Moreno EL; Hachi S; Hemmer K; Trietsch SJ; Baumuratov AS; Hankemeier T; Vulto P; Schwamborn JC; Fleming RM
Lab Chip; 2015 Jun; 15(11):2419-28. PubMed ID: 25902196
[TBL] [Abstract][Full Text] [Related]
31. Real-time and non-invasive impedimetric monitoring of cell proliferation and chemosensitivity in a perfusion 3D cell culture microfluidic chip.
Lei KF; Wu MH; Hsu CW; Chen YD
Biosens Bioelectron; 2014 Jan; 51():16-21. PubMed ID: 23920091
[TBL] [Abstract][Full Text] [Related]
32. Microfluidic perfusion culture of human induced pluripotent stem cells under fully defined culture conditions.
Yoshimitsu R; Hattori K; Sugiura S; Kondo Y; Yamada R; Tachikawa S; Satoh T; Kurisaki A; Ohnuma K; Asashima M; Kanamori T
Biotechnol Bioeng; 2014 May; 111(5):937-47. PubMed ID: 24222619
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device.
van der Meer AD; Orlova VV; ten Dijke P; van den Berg A; Mummery CL
Lab Chip; 2013 Sep; 13(18):3562-8. PubMed ID: 23702711
[TBL] [Abstract][Full Text] [Related]
34. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.
Young EW
Integr Biol (Camb); 2013 Sep; 5(9):1096-109. PubMed ID: 23799587
[TBL] [Abstract][Full Text] [Related]
35. Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.
Rothbauer M; Rosser JM; Zirath H; Ertl P
Curr Opin Biotechnol; 2019 Feb; 55():81-86. PubMed ID: 30189349
[TBL] [Abstract][Full Text] [Related]
36. Human Organs-on-Chips: A Review of the State-of-the-Art, Current Prospects, and Future Challenges.
Zarrintaj P; Saeb MR; Stadler FJ; Yazdi MK; Nezhad MN; Mohebbi S; Seidi F; Ganjali MR; Mozafari M
Adv Biol (Weinh); 2022 Jan; 6(1):e2000526. PubMed ID: 34837667
[TBL] [Abstract][Full Text] [Related]
37. Organ/body-on-a-chip based on microfluidic technology for drug discovery.
Kimura H; Sakai Y; Fujii T
Drug Metab Pharmacokinet; 2018 Feb; 33(1):43-48. PubMed ID: 29175062
[TBL] [Abstract][Full Text] [Related]
38. State-of-the-art technologies: In vitro and in vivo models mimicking the human drug metabolism and pharmacokinetics.
Tabata K; Hirabayashi H
Drug Metab Pharmacokinet; 2018 Feb; 33(1):1. PubMed ID: 29306501
[No Abstract] [Full Text] [Related]
39. Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.
Lee J; Kim S
Curr Drug Metab; 2018; 19(7):577-583. PubMed ID: 29521220
[TBL] [Abstract][Full Text] [Related]
40. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments.
Zhang C; Zhao Z; Abdul Rahim NA; van Noort D; Yu H
Lab Chip; 2009 Nov; 9(22):3185-92. PubMed ID: 19865724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
